Shopping For At-Home Kits, CareStart Antigen COVID-19 Rapid Test Now Fully In Stock At CovCare

FDA authorized, the CareStart Antigen COVID-19 Rapid Test is available through CovCare, offers results within 10 minutes of testing at-home, and is manufactured in the U.S. by Access Bio.

Diagnosing COVID-19 has certainly become more convenient and cheaper with at-home rapid test kits available for purchase. And while getting vaccinated is still the best way to protect against the Coronavirus and its variants, testing at home will play a major role in managing the pandemic in the months ahead. 

The CareStart Antigen COVID-19 Rapid Test by Access Bio is now fully in stock at CovCare, while both the iHealth COVID-19 Antigen Rapid Test and BinaxNOW COVID-19 Antigen Self-Test kits have experienced 1-2 week delays in fulfillment from manufacturers.  For delayed orders, customers can either wait for orders to be fulfilled, contact CovCare to request a refund, or receive a 40% discount on CareStart COVID-19 Antigen Test kits by Access Bio.  

CareStart COVID-19 Antigen Test

The CareStart COVID-19 Antigen Test by AccessBio is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in anterior nares swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.

• - Two tests per kit

• - Rapid results within 10 minutes

• - Available for purchase in amounts of 1, 5, 10, 50, 100, 250, 1,000, OR 5,000 (please contact CovCare directly for information on bulk orders)

• - No lab equipment or additional instruments required.

• - Anterior nares swab specimen collection

• - Designated as a CLIA waived test.

• - FDA Emergency Use Authorization (EUA)

• - Detects SARS-CoV-2 nucleocapsid protein antigen via a lateral flow assay.

• - Manufactured in the U.S. by a U.S. headquartered company

Last week, the U.S. federal government also launched its website to sign up for free Covid-19 tests, allowing the general public to order a maximum of four tests shipped directly to their household with kits being shipped at the end of January.

Health researchers and Coronavirus experts have indicated that at-home rapid tests work by detecting antigens, which are proteins that live on the surface of the virus. Antigen tests are sensitive and vary depending on the amount of virus within one person. In the end, a person needs to produce a higher number of antigens to produce a positive result in a rapid test. While the US Surgeon General, Dr. Vivek Murthy, believes that a nationwide Omicron peak is still likely weeks away from surging, the demand for at-home rapid antigen tests continues to increase. 

It’s becoming increasingly apparent that stocking up on at-home rapid kits to test for COVID-19 is a necessity for households just as facemasks and other PPE items were when the pandemic first began.